Specific overexpression of enolase 2 (ENO2) promotes glycolytic metabolic reprogramming via activating the GSK3β/β-catenin/c-Myc signaling pathway, thus inducing macrophage polarization toward the M2 phenotype and creating a tumor-promoting microenvironment (29). The gene discussed is MYC; the disease is neoplasm.